title: Response to crizotinib observed in metastatic mediastinum lymph node from a non-small cell lung cancer patient harboring EZR-ROS1 fusion.
authors.affiliation: Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, 270 Dong-An Road, Shanghai, 200032, China.
authors.forename: Hang
authors.initials: H
authors.lastname: Li
authors.forename: Yunjian
authors.initials: Y
authors.lastname: Pan
authors.forename: Rui
authors.initials: R
authors.lastname: Wang
authors.forename: Yuan
authors.initials: Y
authors.lastname: Li
authors.forename: Yihua
authors.initials: Y
authors.lastname: Sun
authors.forename: Haiquan
authors.initials: H
authors.lastname: Chen
mesh_terms: D000368:Aged; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D000077547:Crizotinib; D003598:Cytoskeletal Proteins / Q000235:genetics*; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D008207:Lymphatic Metastasis; D008479:Mediastinal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000556:secondary; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed; D000099149:Ezrin
chemical_list: D000077547:Crizotinib; D003598:Cytoskeletal Proteins; D015514:Oncogene Proteins, Fusion; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases; D011518:Proto-Oncogene Proteins; D011720:Pyrazoles; D011725:Pyridines; D000099149:Ezrin; C062333:ROS1 protein, human